159 related articles for article (PubMed ID: 7858736)
1. Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease.
Marazuela M; Vargas JA; Alvarez-Mon M; Albarrán F; Lucas T; Durántez A
Eur J Endocrinol; 1995 Feb; 132(2):175-80. PubMed ID: 7858736
[TBL] [Abstract][Full Text] [Related]
2. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
[TBL] [Abstract][Full Text] [Related]
3. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
[TBL] [Abstract][Full Text] [Related]
4. Depressed natural killer activity in Graves' disease and during antithyroid medication.
Wang PW; Luo SF; Huang BY; Lin JD; Huang MJ
Clin Endocrinol (Oxf); 1988 Feb; 28(2):205-14. PubMed ID: 3168307
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
Wenzel BE; Chow A; Baur R; Schleusener H; Wall JR
Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716
[TBL] [Abstract][Full Text] [Related]
6. Suppressed natural killer cell activity in patients with euthyroid Graves' ophthalmopathy.
Pedersen BK; Perrild H; Feldt-Rasmussen U; Christensen T; Klarlund K; Hansen JM
Autoimmunity; 1989; 2(4):291-8. PubMed ID: 2491612
[TBL] [Abstract][Full Text] [Related]
7. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
Solerte SB; Precerutti S; Gazzaruso C; Locatelli E; Zamboni M; Schifino N; Bonacasa R; Rondanelli M; Taccani D; Ferrari E; Fioravanti M
Eur J Endocrinol; 2005 May; 152(5):703-12. PubMed ID: 15879355
[TBL] [Abstract][Full Text] [Related]
8. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
[TBL] [Abstract][Full Text] [Related]
9. Serial analysis of the effects of methimazole or radical therapy on circulating CD16/56 subpopulations in Graves' disease.
Rojano J; Sasián S; Gavilán I; Aguilar M; Escobar L; Girón JA
Eur J Endocrinol; 1998 Sep; 139(3):314-6. PubMed ID: 9758442
[TBL] [Abstract][Full Text] [Related]
10. Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism.
Stein-Streilein J; Zakarija M; Papic M; McKenzie JM
J Immunol; 1987 Oct; 139(7):2502-7. PubMed ID: 3498760
[TBL] [Abstract][Full Text] [Related]
11. Analysis of circulating T gamma/delta lymphocytes and CD16/56 cell populations in children and adolescents with Graves' disease.
Bossowski A; Urban M; Stasiak-Barmuta A
Pediatr Res; 2003 Sep; 54(3):425-9. PubMed ID: 12761360
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].
Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312
[TBL] [Abstract][Full Text] [Related]
13. Defective response of natural killer activity to thyroxine in Graves' disease.
Lee MS; Hong WS; Hong SW; Lee JO; Kang TW
Korean J Intern Med; 1990 Jul; 5(2):93-6. PubMed ID: 2098098
[TBL] [Abstract][Full Text] [Related]
14. NKG2A expression and impaired function of NK cells in patients with new onset of Graves' disease.
Zhang Y; Lv G; Lou X; Peng D; Qu X; Yang X; Ayana DA; Guo H; Jiang Y
Int Immunopharmacol; 2015 Jan; 24(1):133-9. PubMed ID: 25281394
[TBL] [Abstract][Full Text] [Related]
15. Cellular and antibody mediated cytotoxicity in autoimmune thyroid disease.
Bogner U; Wall JR; Schleusener H
Acta Endocrinol Suppl (Copenh); 1987; 281():133-8. PubMed ID: 3475896
[TBL] [Abstract][Full Text] [Related]
16. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone.
Papic M; Stein-Streilein J; Zakarija M; McKenzie JM; Guffee J; Fletcher MA
J Clin Invest; 1987 Feb; 79(2):404-8. PubMed ID: 3492513
[TBL] [Abstract][Full Text] [Related]
17. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
Heiskala M; Ståhls A; Seppälä I; Timonen T
Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
Bose A; Baral R
Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
[TBL] [Abstract][Full Text] [Related]
19. [Changes of peripheral mononuclear cell subpopulations in autoimmune thyroid diseases].
Tanaka T
Nihon Naibunpi Gakkai Zasshi; 1985 Jul; 61(7):711-23. PubMed ID: 2998893
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 4 (IL-4) blocks the IL-2-induced increased in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma.
Saito S; Umekage H; Nishikawa K; Morii T; Narita N; Enomoto M; Sakakura S; Harada N; Ichijo M; Morikawa H
Cell Immunol; 1996 May; 170(1):71-7. PubMed ID: 8660801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
